Kidney Stones Flashcards

1
Q

___ weather increases stone formation

A

hot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

____% recurrence risk at 5 years

A

50-60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immobilization leads to hyper____

A

hypercalciuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

_____ imaging prior to PCNL

A

Non-con CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MUST obtain ____ before intervention to stratify infection risk

A

UA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ureteral stones <10mm distally should be offered ____

A

alpha-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Re-imaging prior to surgery if stone ____ OR would change management

A

moved/passed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Offer stone treatment if MET is not successful after ____

A

4- weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ is the procedure with lowest morbidity & complication rate

A

ESWL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1st line therapy for mid or distal ureteral stones - ____

A

URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____ is recommended to treat cystine or uric acid ureteral stones

A

URS

Cystine - not well broken down by ESWL

Uric Acid - radiolucent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reasons to not stent

  1. No ____ injury
  2. No ____ stricture
  3. _____ contralateral kidney
  4. ____ AKI
  5. No planned 2nd stage URS
A
  1. No ureteral injury
  2. No ureteral stricture
  3. Normal contralateral kidney
  4. No AKI
  5. No planned 2nd stage URS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pre-stenting should ____ be performed

A

NOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Meds for stent discomfort

A

alpha-blocker

anti-muscarinics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

With infection the first priority is _____

A

decompression of upper tract with stent vs PCN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In patients with <20mm of non-lower pole stones, you can offer ___ OR ____

A

ESWL or URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Total stone burden >2 cm should be treated with ____

A

PCNL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For symptomatic, non-obstructing stones, you can off ____

A

stone treatment

19
Q

May perform ____ when stone filled kidney has negligible function

A

nephrectomy

20
Q

Offer ___ or ___ with symptomatic, <10mm lower pole stones

A

ESWL or URS

21
Q

NTs are ____ in uncomplicated PCNLs

22
Q

Use ___ for irrigation for PCNL & URS

A

normal saline

23
Q

May prescribe ____ to facilitate stone passage s/p ESWL

A

alpha-blocker

24
Q

Do NOT use ____ with pts who have anatomic or functional obstruction

25
____ stones should be treated regardless of symptoms
Staghorn
26
Children always need metabolic evaluation with a ____
24 hr urine
27
In pediatrics with total stones >20 mm, you can offer ___ or ____ with pre-stenting
PCNL ESWL with pre-stenting *no distinction between lower pole*
28
In pregnant pts with ureteral stones, you can offer ____ to pts who fail observation
URS
29
Safest time for stone surgery in pregnancy is ____ trimester
2nd
30
When fragments are present, should offer ____ treatment to render stone free
endoscopic
31
Abort procedure and obtain culture if ____ urine is encountered
purulent
32
In anti-coagulated pts, ____ is 1st line stone therapy
URS
33
Skin to stone distance >____cm is associated with SWL failure
10
34
BMI >____ may prohibit ESWL
30
35
Treatment for 1.8cm lower pole stone in horseshoe kidney
PCNL
36
With ruptured calyx, you can ____
observe
37
Stones resistant to ESWL
CaOx Monohydrate Brushite Cystine
38
Risk factors for uric acid stone formation
T2DM | Obesity
39
Risk factors for hydroxyapatite stone formation
RTA HyperPTH Medullary sponge kidney Carbonic anhydrase inhibitor
40
Pharmacologic therapy for hypercalciuria
Thiazide diuretic
41
Pharmacologic therapy for hyperuricosuria
Allopurinol *in recurrent Ca++ stone formers*
42
Pharmacologic therapy for hypocitraturia
Potassium Citrate
43
Repeat 24 hr urine s/p ____ of dietary or medical intervention
6 months